Modern strategies in therapy of elderly patients with multiple myeloma

Modern strategies in therapy of elderly patients with multiple myeloma

We used the bortezomib plus dexamethasone (VD) and bortezomib plus MP (VMP) in 56 previously untreated elderly patients with multiple myeloma. The patients were 65–89 years old. For patients who received bortezomib plus MP the overall response rate was 83%. 33.3% of patients achieved complete respon...

Full description

Bibliographic Details
Main Authors: S. S. Bessmeltsev, L. V. Stelmashenko, E. V. Kariagina, N. V. Stepanova, G. N. Salogub, T. L. Shelkovskaya, T. A. Malakhova, I. A. Skorokhod, E. I. Podoltseva, N. O. Saraeva, O. I. Kovalev, A. V. Klimovich, N. V. Medvedeva, K. M. Abdulkadyrov, L. I. Krylova, T. H. Potrachkova, M. A. Novikova, E. R. Machulaitene, E. I. Darskaya, L. M. Matukhina, N. A. Kotova, O. Ya. Kostina, I. A. Novokreshchenova
Format: Article
Language:Russian
Published: ABV-press 2022-11-01
Series:Онкогематология
Subjects:
bortezomib
multiple myeloma
treatment
complete remission
overall survival
neuropathy
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/757

Internet

https://oncohematology.abvpress.ru/ongm/article/view/757

Similar Items